Articles about Biotechnology

Biotech stocks are getting crushed — but industry insiders say there’s reason for optimism

Biotech is coming off an epic few years. The sector soared during the pandemic, with venture capital investment and IPO… Read More

Absci’s IPO reflects booming biotech market and growing PNW life sciences industry

The upcoming public offering for Vancouver, Wash.-based biotech company Absci reflects a soaring IPO market and adds to the growing… Read More

Sana Biotechnology boosts IPO range, looks to raise $517 million

Editor’s note: Sana Biotechnology priced shares on Wednesday evening, raising $587.5 million. See full story here. Sana Biotechnology —… Read More

Merck’s multi-billion dollar bet on Seattle Genetics sparks hope for breast cancer treatments

Shares of Seattle Genetics are soaring more than 10% this morning after the Bothell, Wash.-based biotechnology company struck a deal… Read More

This 35-year-old female CEO is about to crack the glass ceiling, shattering a dismal IPO track record

Leen Kawas is truly a unicorn. The 35-year-old co-founder and CEO of Seattle biotechnology company Athira Pharma would be the… Read More

Researcher with Seattle ties awarded $4.2M to develop DNA vaccine against COVID-19

A researcher with ties to Seattle-based biotech company OncoSenX has received a $4.2 million grant from the Canadian Institutes of… Read More

Secretive Seattle biotech company raises more than $700M to develop new ways to modify genes

Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the… Read More

A-Alpha Bio raises $2.8M for genetically engineered drug discovery platform

A Seattle startup that took root at the University of Washington has closed a $2.8 million seed round for a… Read More

Biomatics raises $300M to invest in health startups, adds Gates Foundation global health director

Biomatics Capital, a venture capital firm founded by two Seattle investors with close ties to philanthropists Bill and Melinda Gates,… Read More

Clinical drug screening startup A-Alpha Bio awarded Small Business Innovation Research grant

A-Alpha Bio, a startup aiming to speed up the development of new drugs, announced Tuesday it has won a… Read More

One way to grow Seattle’s biotech economy: Start small

Despite some knock-out successes and world-class research, Seattle’s biotechnology industry has remained relatively small compared to other hubs around the… Read More

Proniras Corp. launches in Seattle, scores $89.5 million contract to develop new seizure drug

Accelerator Life Science Partners, a Seattle-based life sciences investment fund and umbrella company, unveiled its newest company with a bang Friday.… Read More

Stealthy startup Taproot Medical Technologies raises funds to develop next-gen biomaterials

Stealth-mode startup Taproot Medical Technologies has raised $1.25 million out of a $2.25 million round of funding, according to a… Read More

Arzeda raises another $3.2M for synthetic biology that uses fermentation to build new materials

Arzeda does work that sounds out of this world — or maybe straight out of science fiction. The company uses fermentation,… Read More

RightSciences raises cash to develop cannabis and hemp-based medicinal patches

Amid all the hype for recreational marijuana use, it’s easy to forget that cannabis and its related plants are also… Read More

Klatu Networks raises $1 million for predictive IOT platform that protects medical samples

Klatu Networks has a very niche market: The company makes IoT technology that keeps millions of medical samples and treatments… Read More

M3 Biotechnology raises $15.2M, launches clinical trial for drug that could reverse Alzheimer’s

Alzheimer’s remains one of the biggest puzzles in the medical world. It’s a devastating disease that impacts millions of people… Read More

Juno Therapeutics’ giant new Seattle HQ is designed to destroy cancer

When you walk into Juno Therapeutics‘ new headquarters in Seattle, your eyes are immediately drawn to the view. The office’s… Read More

Seattle startup raises $12M to ‘rewrite the software of life’ (with a little help from the technology behind beer)

Proteins are incredibly important, but incredibly complicated, molecules. They control 98 percent of all biological functions and are used in industries… Read More

Genoa Pharmaceuticals raises $62M for clinical trials and names Bruce Montgomery CEO

Genoa Pharmaceuticals — a biopharmaceutical company working on treatments for respiratory diseases — was operating under the radar just last week.… Read More

Q&A: Cancer research leader Nancy Davidson on the innovations of the past decade, and where things are heading next

We often hear that medical research is approaching “breakthroughs” or is at a “tipping point” in innovation. But what does… Read More

Tech Moves: Institute for Systems Biology names president to replace Lee Hood; Seattle VC moves to Silicon Valley; new F5 CEO gets started

Seventeen years after founding the Institute for Systems Biology (ISB), spurring the creation of systems biology as a field, genomics… Read More

Biotechnology